Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

A new method accurately detects bisphenols and parabens in human hair.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

FOXN1 gene variants cause low T cells and immune issues from birth.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Obesity is linked to many gastrointestinal diseases and needs more research for treatment development.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.